CMS Makes It Easier for Healthcare Providers to Choose Axolotl Biologix Products to Spur Wound and Tissue Regeneration

Phoenix, AZ (October 11, 2019) – Axolotl Biologix, an innovative biotechnology leader in regenerative medicine, announced it has obtained Healthcare Common Procedure Coding System (HCPCS) billing codes from the Centers for Medicare and Medicaid Services (CMS) for all its products effective October 1, 2019. “We’re thrilled that the CMS has made it easier for healthcare providers to…

Axolotl Biologix Regenerative Medicine Product Line Approved For Veterans

Axolotl Biologix Regenerative Medicine Product Line Approved For Veterans Physicians At Federal Agencies Can Use Biotechnology To Promote Repair of Damaged Tissues Without Surgery Phoenix, AZ (June 13, 2019) –Axolotl Biologix, a biotechnology leader in regenerative medicine, is thrilled that the General Services Administration (GSA) has added the complete line of Axolotl Biologix’s products to…

Glendale Biotechnology Students Tour Axolotl Biologix Laboratory

Glendale Biotechnology Students Tour Axolotl Biologix Laboratory   Phoenix Company Opens Doors To Encourage STEM Careers Phoenix, AZ (February 21, 2019) –Axolotl Biologix, a biotechnology leader in regenerative medicine, shared some of the secrets of its success with Glendale Community College’s top STEM students. The Phoenix company welcomed members of GCC’s Biotechnology Club to explain…